Skip to main content
Valsamo Anagnostou, MD, Oncology, Baltimore, MD, Johns Hopkins Hospital

ValsamoAnagnostouMDPhD(She/Her)

Oncology • Baltimore, MD

Associate Professor of Oncology at The Johns Hopkins University School of Medicine, Director, Molecular Oncology Lab and Thoracic Oncology Biorepository, Co-director, Thoracic Oncology Precision Medicine Center of Excellence, Co-leader, Johns Hopkins Molecular Tumor Board

Join to view full profile

Dr. Anagnostou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Anagnostou's full profile

Already have an account?

  • Office

    The Bunting Blaustein Cancer Research Building
    1550 Orleans Street
    Baltimore, MD 21287
    Phone+1 410-614-8948
    Fax+1 410-614-8948
  • Is this information wrong?

Summary

  • I am a translational cancer investigator who is focusing on large-scale genomic, multi-omic and liquid biopsy
    analyses in human cancers. My research is particularly focused on understanding the molecular mechanisms of response and resistance to immunotherapy and translating this knowledge into novel technologies and innovative therapeutic approaches for cancer patients treated with immunotherapy. My team's long term goal is to transform medical oncology to molecular oncology, where treatment decisions are tailored not only to a baseline genotype but are also informed by real-time dynamics of liquid biopsies.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 2010 - 2013
  • University of Athens
    University of AthensClass of 2005

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2013 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Immuno-Oncology Trial Endpoints: Capturing Clinically Meaningful Activity  
    Elad Sharon, Patrick M Forde, Valsamo Anagnostou, Hao Wang, Franco Verde, Mark Yarchoan, Clinical Cancer Research

Press Mentions

  • Immunotherapy: Researchers Identify Ways to Help Predict Outcomes for Cancer Treatment
    Immunotherapy: Researchers Identify Ways to Help Predict Outcomes for Cancer TreatmentFebruary 14th, 2023
  • A Large Genomic Analysis Identifies That Persistent Tumour Mutational Burden Is Associated with Immunotherapy Response
    A Large Genomic Analysis Identifies That Persistent Tumour Mutational Burden Is Associated with Immunotherapy ResponseFebruary 6th, 2023
  • ‘Hard to Lose’ Mutations in Tumors May Predict Response to Immunotherapy
    ‘Hard to Lose’ Mutations in Tumors May Predict Response to ImmunotherapyJanuary 26th, 2023
  • Join now to see all

Hospital Affiliations

Dr. Valsamo Anagnostou, Dr. Valsamo Anagnostou, MD, Dr. V Anagnostou